The Mifepristone Briefs Are In, But One Dog Did Not (Yet) Bark
It appears the Supreme Court will decide the fate of telemedicine prescriptions for mifepristone without the benefit of an FDA filing.
Original Source
Read the full article at Reason →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.